79 related articles for article (PubMed ID: 16329995)
21. HPV16 oncogenes E6 or/and E7 may influence the methylation status of RASSFIA gene promoter region in cervical cancer cell line HT-3.
Yin F; Wang N; Wang S; Yu F; Sun X; Yu X; Luo B; Zhao C; Wang Y
Oncol Rep; 2017 Apr; 37(4):2324-2334. PubMed ID: 28260046
[TBL] [Abstract][Full Text] [Related]
22. Suppression of HPV E6 and E7 expression by BAF53 depletion in cervical cancer cells.
Lee K; Lee AY; Kwon YK; Kwon H
Biochem Biophys Res Commun; 2011 Aug; 412(2):328-33. PubMed ID: 21821000
[TBL] [Abstract][Full Text] [Related]
23. E6 and E7 gene silencing results in decreased methylation of tumor suppressor genes and induces phenotype transformation of human cervical carcinoma cell lines.
Li L; Xu C; Long J; Shen D; Zhou W; Zhou Q; Yang J; Jiang M
Oncotarget; 2015 Sep; 6(27):23930-43. PubMed ID: 26329329
[TBL] [Abstract][Full Text] [Related]
24. Transfer of the E6 and E7 genes of human papillomavirus type 18 into human epithelial cells via recombinant retrovirus infection.
Wu CJ; Chang KS; Chang YS
Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1997 Aug; 30(3):123-34. PubMed ID: 10592818
[TBL] [Abstract][Full Text] [Related]
25. MicroRNA-331-3p Suppresses Cervical Cancer Cell Proliferation and E6/E7 Expression by Targeting NRP2.
Fujii T; Shimada K; Asano A; Tatsumi Y; Yamaguchi N; Yamazaki M; Konishi N
Int J Mol Sci; 2016 Aug; 17(8):. PubMed ID: 27548144
[TBL] [Abstract][Full Text] [Related]
26. Selection of human cervical epithelial cells that possess reduced apoptotic potential to low-oxygen conditions.
Kim CY; Tsai MH; Osmanian C; Graeber TG; Lee JE; Giffard RG; DiPaolo JA; Peehl DM; Giaccia AJ
Cancer Res; 1997 Oct; 57(19):4200-4. PubMed ID: 9331075
[TBL] [Abstract][Full Text] [Related]
27. Piwil2 is reactivated by HPV oncoproteins and initiates cell reprogramming via epigenetic regulation during cervical cancer tumorigenesis.
Feng D; Yan K; Zhou Y; Liang H; Liang J; Zhao W; Dong Z; Ling B
Oncotarget; 2016 Oct; 7(40):64575-64588. PubMed ID: 27602489
[TBL] [Abstract][Full Text] [Related]
28. Down-regulation of HPV18 E6, E7, or VEGF expression attenuates malignant biological behavior of human cervical cancer cells.
Chen L; Wu YY; Liu P; Wang J; Wang G; Qin J; Zhou J; Zhu J
Med Oncol; 2011 Dec; 28 Suppl 1():S528-39. PubMed ID: 21222176
[TBL] [Abstract][Full Text] [Related]
29. MiR-9, miR-21, and miR-155 as potential biomarkers for HPV positive and negative cervical cancer.
Park S; Eom K; Kim J; Bang H; Wang HY; Ahn S; Kim G; Jang H; Kim S; Lee D; Park KH; Lee H
BMC Cancer; 2017 Sep; 17(1):658. PubMed ID: 28934937
[TBL] [Abstract][Full Text] [Related]
30. Inhibition of HPV 16 E6 oncogene expression by RNA interference in vitro and in vivo.
Niu XY; Peng ZL; Duan WQ; Wang H; Wang P
Int J Gynecol Cancer; 2006; 16(2):743-51. PubMed ID: 16681755
[TBL] [Abstract][Full Text] [Related]
31. Differentiation-independent constitutive expression of the human papillomavirus type 16 E6 and E7 oncogenes in the CaSki cervical tumour cell line.
Choo CK; Rorke EA; Eckert RL
J Gen Virol; 1994 May; 75 ( Pt 5)():1139-47. PubMed ID: 8176374
[TBL] [Abstract][Full Text] [Related]
32. Human Papillomavirus E6/E7-Specific siRNA Potentiates the Effect of Radiotherapy for Cervical Cancer in Vitro and in Vivo.
Jung HS; Rajasekaran N; Song SY; Kim YD; Hong S; Choi HJ; Kim YS; Choi JS; Choi YL; Shin YK
Int J Mol Sci; 2015 May; 16(6):12243-60. PubMed ID: 26035754
[TBL] [Abstract][Full Text] [Related]
33. Fragile histidine triad transcription abnormalities and human papillomavirus E6-E7 mRNA expression in the development of cervical carcinoma.
Segawa T; Sasagawa T; Yamazaki H; Sakaike J; Ishikawa H; Inoue M
Cancer; 1999 May; 85(9):2001-10. PubMed ID: 10223242
[TBL] [Abstract][Full Text] [Related]
34. Quantitation of human papillomavirus 16 E6 and E7 DNA and RNA in residual material from ThinPrep Papanicolaou tests using real-time polymerase chain reaction analysis.
Wang-Johanning F; Lu DW; Wang Y; Johnson MR; Johanning GL
Cancer; 2002 Apr; 94(8):2199-210. PubMed ID: 12001118
[TBL] [Abstract][Full Text] [Related]
35. Cellular targets of the oncoproteins encoded by the cancer associated human papillomaviruses.
Howley PM; Münger K; Romanczuk H; Scheffner M; Huibregtse JM
Princess Takamatsu Symp; 1991; 22():239-48. PubMed ID: 1668886
[TBL] [Abstract][Full Text] [Related]
36. N-Benzylcinnamide induces apoptosis in HPV16 and HPV18 cervical cancer cells via suppression of E6 and E7 protein expression.
Xiong Y; Chen L; Luo P
IUBMB Life; 2015 May; 67(5):374-9. PubMed ID: 25914202
[TBL] [Abstract][Full Text] [Related]
37. Arsenic trioxide inhibits cell proliferation and human papillomavirus oncogene expression in cervical cancer cells.
Wang H; Gao P; Zheng J
Biochem Biophys Res Commun; 2014 Sep; 451(4):556-61. PubMed ID: 25117446
[TBL] [Abstract][Full Text] [Related]
38. Both Rb and E7 are regulated by the ubiquitin proteasome pathway in HPV-containing cervical tumor cells.
Wang J; Sampath A; Raychaudhuri P; Bagchi S
Oncogene; 2001 Aug; 20(34):4740-9. PubMed ID: 11498796
[TBL] [Abstract][Full Text] [Related]
39. O-linked N-acetylglucosamine transferase promotes cervical cancer tumorigenesis through human papillomaviruses E6 and E7 oncogenes.
Kim M; Kim YS; Kim H; Kang MY; Park J; Lee DH; Roh GS; Kim HJ; Kang SS; Cho GJ; Park JK; Cho JW; Shin JK; Choi WS
Oncotarget; 2016 Jul; 7(28):44596-44607. PubMed ID: 27331873
[TBL] [Abstract][Full Text] [Related]
40. HPV16 E6 and E7 oncoproteins regulate Notch-1 expression and cooperate to induce transformation.
Weijzen S; Zlobin A; Braid M; Miele L; Kast WM
J Cell Physiol; 2003 Mar; 194(3):356-62. PubMed ID: 12548555
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
